Redox signaling, vascular function, and hypertension

Antioxidants and Redox Signaling

Volumn 10, Issue 6, 2008, Pages 1045-1059

  Lee, Moo Yeol ^a   Griendling, Kathy K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 [3 METHOXY 4 (PHENYLSULFINYL)PHENYL]PYRAZOLO[1,5 A][1,3,5]TRIAZIN 4 OL; ACETYLCYSTEINE; ALLOPURINOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIPURINOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL; TUNGSTEN; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CELL DEATH; CELL GROWTH; CELL MIGRATION; DISEASE COURSE; DRUG MECHANISM; ELECTRON TRANSPORT; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; HYPERTENSION; MITOCHONDRION; MUSCLE CONTRACTILITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOMOTOR DISORDER;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATION;

EID: 41349099837     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1986     Document Type: Review

References (247)

1. Abdel-Sayed S, Nussberger J, Aubert JF, Gohlke P, Brunner HR, and Brakch N. Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects. Am J Hypertens 16: 515-521, 2003.
2. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, and Redon J. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 21: 68-75, 2007.
3. Alexander BT, Cockrell KL, Rinewalt AN, Herrington JN, and Granger JP. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 280: R1388-1392, 2001.
4. Allcock GH, Venema RC, and Pollock DM. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Am J Physiol 275: R245-252, 1998.
5. Alvarez B, Demicheli V, Duran R, Trujillo M, Cervenansky C, Freeman BA, and Radi R. Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med 37: 813-822, 2004.
6. Amberg GC, Bonev AD, Rossow CF, Nelson MT, and Santanxa LF. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112: 717-724, 2003.
7. Antonios TF, Singer DR, Markandu ND, Mortimer PS, and MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34: 655-658, 1999.
8. Antonios TF, Singer DR, Markandu ND, Mortimer PS, and MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 33: 998-1001, 1999.
9. Aon MA, Cortassa S, and O'Rourke B. Percolation and criticality in a mitochondrial network. Proc Natl Acad Sci USA 101: 4447-4452, 2004.
10. Ardanaz N and Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 231: 237-251, 2006.
11. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, and Runge MS. Mitochondrial integrity and function in atherogenesis. Circulation 106: 544-549, 2002.
12. Banday AA, Muhammad AB, Fazili FR, and Lokhandwala M. Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 49: 664-671, 2007.
13. Barlow RS, El-Mowafy AM, and White RE. H(2)O(2) opens BK(Ca) channels via the PLA(2)-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 279: H475-483, 2000.
14. Berry CE and Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555: 589-606, 2004.
15. Beswick RA, Dorrance AM, Leite R, and Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107-1111, 2001.
16. Brakemeier S, Eichler I, Knorr A, Fassheber T, Kohler R, and Hoyer J. Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species. Kidney Int 64: 199-207, 2003.
17. Bratz IN, Falcon R, Partridge LD, and Kanagy NL. Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension. Am J Physiol Heart Circ Physiol 282: H1648-1655, 2002.
18. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, and Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42: 415-423, 2005.
19. Burke TM, and Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 252: H721-732, 1987.
20. Callera GE, Tostes RC, Yogi A, Montezano AC, and Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Lond) 110: 243-253, 2006.
21. Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, and Tostes RC. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42: 811-817, 2003.
22. Cannon PJ, Stason WB, Demartini FE, Sommers SC, and Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med 275: 457-464, 1966.
23. Cardillo C, Kilcoyne CM, Cannon RO, 3rd, Quyyumi AA, and Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30: 57-63, 1997.
24. Ceriello A, Giugliano D, Quatraro A, and Lefebvre PJ. Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) 81: 739-742, 1991.
25. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
26. Chalupsky K and Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 102: 9056-9061, 2005.
27. Chen X, Touyz RM, Park JB, and Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38: 606-611, 2001.
28. Ciuffetti G, Schillaci G, Innocente S, Lombardini R, Pasqualini L, Notaristefano S, and Mannarino E. Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens 21: 2297-2303, 2003.
29. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, Schmidt HH, Lassegue B, and Griendling KK. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27: 42-48, 2007.
30. Colavitti R and Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57: 277-281, 2005.
31. Contard F, Sabri A, Glukhova M, Sartore S, Marotte F, Pomies JP, Schiavi P, Guez D, Samuel JL, and Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 22: 665-676, 1993.
32. Cosentino F and Luscher TF. Tetrahydrobiopterin and endothelial function. Eur Heart J 19 Suppl G: G3-8, 1998.
33. Cox RH, Lozinskaya I, Matsuda K, and Dietz NJ. Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats. Am J Hypertens 15: 879-890, 2002.
34. Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, and Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 41: 286-288, 2003.
35. d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, and Luscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 29: 435-441, 1997.
36. Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, and Cicero AF. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 13: 227-231, 2006.
37. Devlin AM, Clark JS, Reid JL, and Dominiczak AF. DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. Hypertension 36: 110-115, 2000.
38. Diep QN, Li JS, and Schiffrin EL. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension 34: 617-624, 1999.
39. Diep QN, Touyz RM, and Schiffrin EL. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36: 851-855, 2000.
40. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, and Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112: 2668-2676, 2005.
41. Dobrian AD, Schriver SD, and Prewitt RL. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 38: 361-366, 2001.
42. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 24: 983-991, 2006.
43. Elmarakby AA, Loomis ED, Pollock JS, and Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45: 283-287, 2005.
44. Ergul A. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Hypertension 36: 62-67, 2000.
45. Escalante BA, McGiff JC, and Oyekan AO. Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule. Am J Physiol Renal Physiol 282: F144-150, 2002.
46. Favero TG, Zable AC, and Abramson JJ. Hydrogen peroxide stimulates the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. J Biol Chem 270: 25557-25563, 1995.
47. Feihl F, Liaudet L, Waeber B, and Levy BI. Hypertension: a disease of the microcirculation? Hypertension 48: 1012-1017, 2006.
48. Feletou M, and Vanhoutte PM. Endothelial dysfunction: a multi-faceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985-1002, 2006.
49. Forstermann U and Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714, 2006.
50. Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, and Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22: 2169-2175, 2004.
51. Fujimoto S, Asano T, Sakai M, Sakurai K, Takagi D, Yoshimoto N, and Itoh T. Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery. Eur J Pharmacol 412: 291-300, 2001.
52. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Qt, Taylor WR, Harrison DG, de Leon H, Wilcox JN, and Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1997.
53. Funder JW. Cardiovascular endocrinology: into the new millennium. Trends Endocrinol Metab 12: 283-285, 2001.
54. Galley HF, Thornton J, Howdle PD, Walker BE, and Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond) 92: 361-365, 1997.
55. Gao YJ, Hirota S, Zhang DW, Janssen LJ, and Lee RM. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 138: 1085-1092, 2003.
56. Gao YJ, Zhang Y, Hirota S, Janssen LJ, and Lee RM. Vascular relaxation response to hydrogen peroxide is impaired in hypertension. Br J Pharmacol 142: 143-149, 2004.
57. Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607-621, 2007.
58. Giannelli G, Iannone F, Marinosci F, Lapadula G, and Antonaci S. The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension. Curr Med Res Opin 21: 327-332, 2005.
59. Goto K, Rummery NM, Grayson TH, and Hill CE. Attenuation of conducted vasodilatation in rat mesenteric arteries during hypertension: role of inwardly rectifying potassium channels. J Physiol 561: 215-231, 2004.
60. Greene EL, Lu G, Zhang D, and Egan BM. Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension 37: 308-312, 2001.
61. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
62. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92: e80-86, 2003.
63. Grover AK, and Samson SE. Effect of superoxide radical on Ca2+ pumps of coronary artery. Am J Physiol 255: C297-303, 1988.
64. Grover AK, Samson SE, and Fomin VP. Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol 263: H537-543, 1992.
65. Grover AK, Samson SE, Robinson S, and Kwan CY. Effects of peroxynitrite on sarcoplasmic reticulum Ca2+ pump in pig coronary artery smooth muscle. Am J Physiol Cell Physiol 284: C294-301, 2003.
66. Gurjar MV, DeLeon J, Sharma RV, and Bhalla RC. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. J Appl Physiol 91: 1380-1386, 2001.
67. Gutterman DD, Miura H, and Liu Y. Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25: 671-678, 2005.
68. Hadrava V, Tremblay J, and Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 13: 589-597, 1989.
69. Hamet P, deBlois D, Dam TV, Richard L, Teiger E, Tea BS, Orlov SN, and Tremblay J. Apoptosis and vascular wall remodeling in hypertension. Can J Physiol Pharmacol 74: 850-861, 1996.
70. Harris CM, Sanders SA, and Massey V. Role of the flavin midpoint potential and NAD binding in determining NAD versus oxygen reactivity of xanthine oxidoreductase. J Biol Chem 274: 4561-4569, 1999.
71. Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, Selvakumar B, Ma Q, Moustafa-Bayoumi M, Binkley PF, Flavahan NA, Morris M, Dong C, and Goldschmidt-Clermont PJ. Hypertension caused by transgenic overexpression of Rac1. Antioxid Redox Signal 9: 91-100, 2007.
72. Heerkens EH, Izzard AS, and Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension 49: 1-4, 2007.
73. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
74. Higashi Y, Sasaki S, Nakagawa K, Fukuda Y, Matsuura H, Oshima T, and Chayama K. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens 15: 326-332, 2002.
75. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002.
76. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
77. Hu WY, Fukuda N, and Kanmatsuse K. Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J Hypertens 20: 1323-1333, 2002.
78. Iida Y, and Katusic ZS. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 31: 2224-2230, 2000.
79. Irani K. Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87: 179-183, 2000.
80. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CX, and Laurindo FR. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 280: 40813-40819, 2005.
81. Jin L, Ying Z, Hilgers RH, Yin J, Zhao X, Imig JD, and Webb RC. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats. J Pharmacol Exp Ther 318: 288-295, 2006.
82. Jin L, Ying Z, and Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287: H1495-1500, 2004.
83. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, and Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA 93: 11848-11852, 1996.
84. Kaehler J, Sill B, Koester R, Mittmann C, Orzechowski HD, Muenzel T, and Meinertz T. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 103 Suppl 48: 176S-178S, 2002.
85. Kaplan P, Babusikova E, Lehotsky J, and Dobrota D. Free radical-induced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum. Mol Cell Biochem 248: 4147, 2003.
86. Kappert K, Sparwel J, Sandin A, Seiler A, Siebolts U, Leppanen O, Rosenkranz S, and Ostman A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol 26: 26442651, 2006.
87. Katusic ZS and Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 257: H3337, 1989.
88. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, and Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33: 1353-1358, 1999.
89. Kim J, Min G, Bae YS, and Min DS. Phospholipase D is involved in oxidative stress-induced migration of vascular smooth muscle cells via tyrosine phosphorylation and protein kinase C. Exp Mol Med 36: 103-109, 2004.
90. Kitamoto S, Egashira K, Kataoka C, Usui M, Koyanagi M, Takemoto M, and Takeshita A. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18: 1795-1800, 2000.
91. Kobayashi N, DeLano FA, and Schmid-Schonbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 25: 2114-2121, 2005.
92. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, and Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 22: 523-526, 1993.
93. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 275: C1-24, 1998.
94. Kuzkaya N, Weissmann N, Harrison DG, and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
95. Laakso J, Mervaala E, Himberg JJ, Teravainen TL, Karppanen H, Vapaatalo H, and Lapatto R. Increased kidney xanthine oxidore-ductase activity in salt-induced experimental hypertension. Hypertension 32: 902-906, 1998.
96. Lacy F, O'Connor DT, and Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-303, 1998.
97. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511-515, 2002.
98. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
99. Landmesser U and Harrison DG. Oxidative stress and vascular damage in hypertension. Coron Artery Dis 12: 455-461, 2001.
100. Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, and Drexler H. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27: 943-948, 2007.
101. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-297, 2003.
102. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
103. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
104. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, and Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98: 535-540, 1998.
105. Lee VM, Quinn PA, Jennings SC, and Ng LL. Neutrophil activation and production of reactive oxygen species in pre-eclampsia. J Hypertens 21: 395-402, 2003.
106. Li JM, Wheatcroft S, Fan LM, Kearney MT, and Shah AM. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109: 1307-1313, 2004.
107. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, and Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
108. Li PF, Dietz R, and von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96: 3602-3609, 1997.
109. Li PF, Dietz R, and von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404: 249-252, 1997.
110. Li PF, Maasch C, Haller H, Dietz R, and von Harsdorf R. Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. Circulation 100: 967-973, 1999.
111. Li-Saw-Hee FL, Edmunds E, Blann AD, Beevers DG, and Lip GY. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol 75: 43-47, 2000.
112. Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, and Beevers DG. Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16: 333-336, 2002.
113. Liu W, Rosenberg GA, Shi H, Furuichi T, Timmins GS, Cunningham LA, and Liu KJ. Xanthine oxidase activates pro-matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells through non-free radical mechanisms. Arch Biochem Biophys 426: 11-17, 2004.
114. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, and Gutterman DD. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 91: 1070-1076, 2002.
115. Lo IC, Shih JM, and Jiang MJ. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci 12: 377-388, 2005.
116. Loirand G, Rolli-Derkinderen M, and Pacaud P. RhoA and resistance artery remodeling. Am J Physiol Heart Circ Physiol 288: H1051-1056, 2005.
117. Loomis ED, Sullivan JC, Osmond DA, Pollock DM, and Pollock JS. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitricoxide synthase in the rat aorta. J Pharmacol Exp Ther 315: 1058-1064, 2005.
118. Lucchesi PA, Belmadani S, and Matrougui K. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J Hypertens 23: 571-579, 2005.
119. Mahadevan VS, Campbell M, McKeown PP, and Bayraktutan U. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc Res 72: 60-68, 2006.
120. Martens JR and Gelband CH. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension. Circ Res 79: 295-301, 1996.
121. Martens JR and Gelband CH. Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med 218: 192-203, 1998.
122. Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF, and Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol 47: 117-122, 2006.
123. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, and Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38: 1307-1310, 2001.
124. Matesanz N, Lafuente N, Azcutia V, Martin D, Cuadrado A, Nevado J, Rodriguez-Manas L, Sanchez-Ferrer CF, and Peiro C. Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. J Hypertens 25: 609-618, 2007.
125. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
126. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai Y, Hirakawa Y, Akaike T, and Takeshita A. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 23: 1224-1230, 2003.
127. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
128. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677-2685, 2005.
129. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, and Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285: H2290-2297, 2003.
130. Michelakis ED. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications. Circ Res 98: 172-175, 2006.
131. Mitani Y, Ueda M, Komatsu R, Maruyama K, Nagai R, Matsumura M, and Sakurai M. Vascular smooth muscle cell phenotypes in primary pulmonary hypertension. Eur Respir J 17: 316-320, 2001.
132. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-65, 2002.
133. Mueller CF, Laude K, McNally JS, and Harrison DG. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25: 274-278, 2005.
134. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, and Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15: 1062-1064, 2001.
135. Mulvany MJ. Small artery remodeling in hypertension. Curr Hypertens Rep 4: 49-55, 2002.
136. Munzel T, Daiber A, Ullrich V, and Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25: 1551-1557, 2005.
137. Nabha L, Garbern JC, Buller CL, and Charpie JR. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens 27: 71-82, 2005.
138. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, and Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88: 10045-10048, 1991.
139. Nemeth I, Talosi G, Papp A, and Boda D. Xanthine oxidase activation in mild gestational hypertension. Hypertens Pregnancy 21: 1-11, 2002.
140. Newaz MA, Adeeb NN, Muslim N, Razak TA, and Htut NN. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin Exp Hypertens 18: 1035-1050, 1996.
141. Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, Strehlow K, and Bohm M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J 16: 1077-1086, 2002.
142. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
143. Nishio E and Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 121: 665-670, 1997.
144. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, and Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99: 1873-1879, 1997.
145. Oeckler RA, Arcuino E, Ahmad M, Olson SC, and Wolin MS. Cytosolic NADH redox and thiol oxidation regulate pulmonary arterial force through ERK MAP kinase. Am J Physiol Lung Cell Mol Physiol 288: L1017-1025, 2005.
146. Oeckler RA, Kaminski PM, and Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92: 23-31, 2003.
147. Ortiz MC, Sanabria E, Manriquez MC, Romero JC, and Juncos LA. Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension 37: 505-510, 2001.
148. Owens GK, Kumar MS, and Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004.
149. Owens GK and Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 51: 280-289, 1982.
150. Papaharalambus CA, and Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17: 48-54, 2007.
151. Patel R, Cardneau JD, Colles SM, and Graham LM. Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: effect on collagen secretion. J Vasc Surg 43: 364-371, 2006.
152. Pauletto P, Chiavegato A, Giuriato L, Scatena M, Faggin E, Grisenti A, Sarzani R, Paci MV, Fulgeri PD, Rappelli A, and et al. Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype. Circ Res 74: 774-788, 1994.
153. Pechanova O, Zicha J, Kojsova S, Dobesova Z, Jendekova L, and Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci (Lond) 110: 235-242, 2006.
154. Perez-Rivero G, Ruiz-Torres MP, Rivas-Elena JV, Jerkic M, Diez-Marques ML, Lopez-Novoa JM, Blasco MA, and Rodriguez-Puyol D. Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation 114: 309-317, 2006.
155. Pettit AI, Wong RK, Lee V, Jennings S, Quinn PA, and Ng LL. Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22(phox) in lymphoblast cell lines. J Hypertens 20: 677-683, 2002.
156. Pollock DM. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 45: 477-480, 2005.
157. Price DT, Vita JA, and Keaney JF, Jr. Redox control of vascular nitric oxide bioavailability. Antioxid Redox Signal 2: 919-935, 2000.
158. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
159. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, and Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 30: 29-34, 1997.
160. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579, 1996.
161. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC, and Darley-Usmar V. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 33: 1465-1474, 2002.
162. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, and Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003.
163. Remuzzi G, Perico N, and Benigni A. New therapeutics that antagonize endothelin: promises and frustrations. Nat Rev Drug Discov 1: 986-1001, 2002.
164. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, and Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89: 408-414, 2001.
165. Rizzoni D, Porteri E, Guefi D, Piccoli A, Castellano M, Pasini G, Muiesan ML, Mulvany MJ, and Rosei EA. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 35: 931-935, 2000.
166. Rizzoni D, Rodella L, Porteri E, Rezzani R, Guelfi D, Piccoli A, Castellano M, Muiesan ML, Bianchi R, and Rosei EA. Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats. J Hypertens 18: 885-891, 2000.
167. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, and Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
168. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, and Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329-1335, 1998.
169. Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, and Redon J. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens 17: 809-816, 2004.
170. Sakuma S, Fujimoto Y, Sakamoto Y, Uchiyama T, Yoshioka K, Nishida H, and Fujita T. Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochem Biophys Res Commun 230: 476-479, 1997.
171. Sasser JM, Pollock JS, and Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 283: R243-248, 2002.
172. Sato A, Sakuma I, and Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 285: H2345-2354, 2003.
173. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17: 1192-1200, 2004.
174. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, and Rabinovitch PS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308: 1909-1911, 2005.
175. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, and Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42: 806-810, 2003.
176. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, and Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
177. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, and Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 38: 238-242, 2001.
178. Sharifi AM and Schiffrin EL. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism. J Hypertens 15: 1441-1448, 1997.
179. Shi M, Yang H, Motley ED, and Guo Z. Overexpression of Cu/Zn-superoxide dismutase and/or catalase in mice inhibits aorta smooth muscle cell proliferation. Am J Hypertens 17: 450-456, 2004.
180. Simic D, Perunicic J, Lasica R, Ivanovic B, Matic D, Kalimanovska-Ostric D, Vranic I, Medenica M, Mimic-Oka J, and Simic T. [Plasma and red blood cell superoxide dismutase activity in patients with different stages of essential hypertension]. Med Arh 59: 156-159, 2005.
181. Somers MJ, Mavromatis K, Galis ZS, and Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
182. Soto MA, Gonzalez C, Lissi E, Vergara C, and Latorre R. Ca(2+)-activated K+ channel inhibition by reactive oxygen species. Am J Physiol Cell Physiol 282: C461-471, 2002.
183. Spiers JP, Kelso EJ, Siah WF, Edge G, Song G, McDermott BJ, and Hennessy M. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. J Hypertens 23: 1717-1724, 2005.
184. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-Clermont PJ, and Flavahan NA. Redox regulation of vascular smooth muscle cell differentiation. Circ Res 89: 39-46, 2001.
185. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
186. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
187. Sung HJ, Eskin SG, Sakurai Y, Yee A, Kataoka N, and McIntire LV. Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells. Ann Biomed Eng 33: 1546-1554, 2005.
188. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, and Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95: 4754-4759, 1998.
189. Suzuki YJ and Ford GD. Superoxide stimulates IP3-induced Ca2+ release from vascular smooth muscle sarcoplasmic reticulum. Am J Physiol 262: H114-116, 1992.
190. Swei A, Lacy F, Delano FA, Parks DA, and Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation 6: 179-187, 1999.
191. Szasz T, Thakali K, Fink GD, and Watts SW. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232: 27-37, 2007.
192. Tabet F, Savoia C, Schiffrin EL, and Touyz RM. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 44: 200-208, 2004.
193. Taddei S, Virdis A, Ghiadoni L, Magagna A, and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
194. Takimoto E and Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49: 241-248, 2007.
195. Tang XD, Daggett H, Hanner M, Garcia ML, McManus OB, Brot N, Weissbach H, Heinemann SH, and Hoshi T. Oxidative regulation of large conductance calcium-activated potassium channels. J Gen Physiol 117: 253-274, 2001.
196. Tao J, Zhang Y, Soong TW, and Li S. Urocortin II inhibits the apoptosis of mesenteric arterial smooth muscle cells via L-type calcium channels in spontaneously hypertensive rats. Cell Physiol Biochem 17: 111-120, 2006.
197. Tayebjee MH, Karalis I, Nadar SK, Beevers DG, MacFadyen RJ, and Lip GY. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am J Hypertens 18: 325-329, 2005.
198. Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, and Lip GY. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens 17: 764-769, 2004.
199. Tayebjee MH, Nadar SK, MacFadyen RJ, and Lip GY. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. Am J Hypertens 17: 770-774, 2004.
200. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, and Rosenkranz S. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71: 331-341, 2006.
201. Teramoto N. Physiological roles of ATP-sensitive K+ channels in smooth muscle. J Physiol 572: 617-624, 2006.
202. Thakali K, Demel SL, Fink GD, and Watts SW. Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. Am J Physiol Heart Circ Physiol 289: H1115-1122, 2005.
203. Thengchaisri N and Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol 285: H2255-2263, 2003.
204. Thorneloe KS and Nelson MT. Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can J Physiol Pharmacol 83: 215-242, 2005.
205. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90: 449-455, 2005.
206. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 7: 1302-1314, 2005.
207. Touyz RM and Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
208. Ushio-Fukai M, Alexander RW, Akers M, and Griendling KK. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998.
209. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, and Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-22704, 1999.
210. Vaziri ND, Wang XQ, Oveisi F, and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
211. Vega F, Panizo A, Pardo-Mindan J, and Diez J. Susceptibility to apoptosis measured by MYC, BCL-2, and BAX expression in arterioles and capillaries of adult spontaneously hypertensive rats. Am J Hypertens 12: 815-820, 1999.
212. Vogt CJ and Schmid-Schonbein GW. Microvascular endothelial cell death and rarefaction in the glucocorticoid-induced hypertensive rat. Microcirculation 8: 129-139, 2001.
213. Wallwork CJ, Parks DA, and Schmid-Schonbein GW. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 66: 30-37, 2003.
214. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, and Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88: 947-953, 2001.
215. Wang Y and Wang DH. Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am J Physiol Heart Circ Physiol 287: H1868-1874, 2004.
216. Wang Z, Castresana MR, and Newman WH. Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochem Biophys Res Commun 285: 669-674, 2001.
217. Wang Z, Castresana MR, and Newman WH. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J Mol Cell Cardiol 36: 49-56, 2004.
218. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, and Griendling KK. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 94: 1219-1226, 2004.
219. Wedgwood S, Dettman RW, and Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281: L1058-1067, 2001.
220. Wehrwein EA, Northcott CA, Loberg RD, and Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 309: 1011-1019, 2004.
221. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, and Wilcox CS. Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48: 934-941, 2006.
222. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-935, 2005.
223. Wolin MS, Gupte SA, and Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191-207, 2002.
224. Xi XP, Graf K, Goetze S, Fleck E, Hsueh WA, and Law RE. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 73-82, 1999.
225. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, and Kajiya F. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107: 1040-1045, 2003.
226. Yamada T, Horiuchi M, and Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156-160, 1996.
227. Yang M, Foster E, and Kahn AM. Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens 18: 1329-1334, 2005.
228. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, and Wilkinson IB. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25: 372, 2005.
229. Yasunari K, Maeda K, Minami M, and Yoshikawa J. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscler Thromb Vasc Biol 21: 937-942, 2001.
230. Yasunari K, Maeda K, Nakamura M, and Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 39: 433-437, 2002.
231. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, and Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998.
232. Zaidi A and Michaelis ML. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase. Free Radic Biol Med 27: 810-821, 1999.
233. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, and Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35: 1055-1061, 2000.
234. Zalba G, San Jose G, Moreno MU, Fortuno A, and Diez J. NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxid Redox Signal 7: 1327-1336, 2005.
235. Zervoudaki A, Economou E, Pitsavos C, Vasiliadou K, Aggeli C, Tsioufis K, Toutouza M, Stefanadis C, and Toutouzas P. The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension. Am J Hypertens 17: 273-276, 2004.
236. Zervoudaki A, Economou E, Stefanadis C, Pitsavos C, Tsioufis K, Aggeli C, Vasiliadou K, Toutouza M, and Toutouzas P. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. J Hum Hypertens 17: 119-124, 2003.
237. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, Sessa WC, and Min W. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 170: 1108-1120, 2007.
238. Zhang Y, Griendling KK, Dikalova A, Owens GK, and Taylor WR. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 46: 732-737, 2005.
239. Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G, Kovesdi I, and Chen AF. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108: 1238-1245, 2003.
240. Zhou L, Xiang W, Potts J, Floyd M, Sharan C, Yang H, Ross J, Nyanda AM, and Guo Z. Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 41: 1384-1391, 2006.
241. Zhou MS, Jaimes EA, and Raij L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens 23: 1737-1743, 2005.
242. Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AJ, Gavras H, and Baldwin CT. Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 21: 3-7, 2005.
243. Zhou XJ, Vaziri ND, Wang XQ, Silva FG, and Laszik Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 300: 762-767, 2002.
244. Zou MH. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82: 119-127, 2007.
245. Zou MH, Cohen R, and Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97, 2004.
246. Zou MH, Shi C, and Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.
247. Zucker IH. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48: 1005-1011, 2006.